JeffreyRobertBenderMD

Preventive Cardiology

Robert I. Levy Prof. of Cardiology, Director Yale Cardiovascular Research Center, Assoc. Chief, Cardiovascular Medicine, Yale U. School. of Medicine

Join to view full profile

Dr. Bender is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bender's full profile

Already have an account?

Office
800 Howard Ave
Yale Physicians Building
New Haven, CT 06519
Phone+1 203-785-2140

Education & Training

Stanford Health CarePost-Doctoral Fellowship, 1984 - 1988
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1983 - 1986
Yale-New Haven Medical CenterChief Residency, Internal Medicine, 1982 - 1983
Yale-New Haven Medical CenterResidency, Internal Medicine, 1979 - 1982
University of California San Francisco School of MedicineClass of 1979

Certifications & Licensure

CT State Medical License 1988 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

President Association of University Cardiologists, 2013
Elected member Association of American Physicians, 2002
Robert I. Levy Endowed Professorship Yale University, 2002
Elected Member The American Society for Clinical Investigation, 1996
Join now to see all

Publications & Presentations

PubMed

409 citations
17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization.
Teresa Caulin-Glaser, Guillermo García-Cardeña, P.M. Sarrel, William C. Sessa, Jeffrey R. Bender
Circulation Research. 1997-11-01
78 citations
Monoclonal antibodies reactive with subsets of mouse and human thymic epithelial cells.
Robert V. Rouse, Laurel M. Bolin, Jeffrey R. Bender, Bruno Kyewski
The Journal of Histochemistry and Cytochemistry. 1988-12-01
19 citations
CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation.
Fatemehsadat Esteghamat, James S. Broughton, Emily Smith, Rebecca L. Cardone, Tarun Tyagi
Nature Genetics. 2019-07-29

Grant Support

Vascular disease pathogenesis: interface between smooth muscle and immune cellsNIH2018–2023
Competitive Macrophage MicroRNA-RNA Binding Protein Interactions in Wound RepairNIH2017–2022
Therapeutic miRNA target site blocking oligonucleotide in autoimmune/inflammatory diseaseBlavatnik Fund for Innovation2018–2020
Therapeutic inhibition of MIF to restore glucocorticoid responseNIH2017–2019
Modulating Neuroinflammation through interference of cooperative microRNA - RNA-binding protein interactionsNIH2016–2018
Macrophage integrin-modulated RNA stability in neovessel formationState of Connecticut Public Health2015–2018
Molecular Models Of Estrogen-Induced Vascular ProtectionNational Heart, Lung, And Blood Institute2003–2011
Vascular Research TrainingNational Heart, Lung, And Blood Institute2000–2011
Molecular Models Of Immune-Mediated Vascular InjuryNational Heart, Lung, And Blood Institute1994–2011
An Ifn-Y-Integrin-Growth Factor Axis In GA Biomarker DevelopmentNational Heart, Lung, And Blood Institute2006–2010
Molecular Models Of Estrogen-Induced Vascular ProtectionNational Heart, Lung, And Blood Institute2007
Imaging DTH, IFN Gamma Responses &Ga In Human ArteriesNational Heart, Lung, And Blood Institute2001–2005
Contact Dependent Endothelial Activation By NK CellsNational Heart, Lung, And Blood Institute1999–2003
Molecular Models Of Estrogen Induced Vascular ProtectionNational Heart, Lung, And Blood Institute1999–2002
Molecular Models Of Immune Mediated Vascular InjuryNational Heart, Lung, And Blood Institute1991–2001
Contact Dependent Endothelial HLA Induction By NK CellsNational Heart, Lung, And Blood Institute1995–1998
Lymphocyte--Endothelial Cell Molecular InteractionsNational Heart, Lung, And Blood Institute1988–1991
T Lymphocytes In Human Heart Transplant RejectionNational Heart, Lung, And Blood Institute1985